SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Marie E. Oskarsson, Johan F. Paulsson, Sebastian W. Schultz, Martin Ingelsson, Per Westermark, Gunilla T. Westermark, In Vivo Seeding and Cross-Seeding of Localized Amyloidosis, The American Journal of Pathology, 2015, 185, 3, 834

    CrossRef

  2. 2
    Wei Qiao Qiu, Haihao Zhu, Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?, Frontiers in Aging Neuroscience, 2014, 6,

    CrossRef

  3. 3
    Omid Tavassoly, Sergiy Nokhrin, Oleg Y. Dmitriev, Jeremy S. Lee, Cu(II) and dopamine bind to α-synuclein and cause large conformational changes, FEBS Journal, 2014, 281, 12
  4. 4
    Geert Jan Biessels, Mark W J Strachan, Frank L J Visseren, L Jaap Kappelle, Rachel A Whitmer, Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions, The Lancet Diabetes & Endocrinology, 2014, 2, 3, 246

    CrossRef

  5. 5
    H Zhu, X Wang, M Wallack, H Li, I Carreras, A Dedeoglu, J-Y Hur, H Zheng, H Li, R Fine, M Mwamburi, X Sun, N Kowall, R A Stern, W Q Qiu, Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer’s disease, Molecular Psychiatry, 2014,

    CrossRef

  6. 6
    Jill K. Morris, Robyn A. Honea, Eric D. Vidoni, Russell H. Swerdlow, Jeffrey M. Burns, Is Alzheimer's disease a systemic disease?, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014, 1842, 9, 1340

    CrossRef

  7. 7
    Juvenal A. Ríos, Pedro Cisternas, Marco Arrese, Salesa Barja, Nibaldo C. Inestrosa, Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum, Progress in Neurobiology, 2014, 121, 125

    CrossRef

  8. 8
    Brittany L. Adler, Mark Yarchoan, Hae Min Hwang, Natalia Louneva, Jeffrey A. Blair, Russell Palm, Mark A. Smith, Hyoung-gon Lee, Steven E. Arnold, Gemma Casadesus, Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition, Neurobiology of Aging, 2014, 35, 4, 793

    CrossRef

  9. 9
    M. Yarchoan, S. E. Arnold, Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease, Diabetes, 2014, 63, 7, 2253

    CrossRef

  10. 10
    Tamás Vajda, András Perczel, Role of water in protein folding, oligomerization, amyloidosis and miniprotein, Journal of Peptide Science, 2014, 20, 10
  11. 11
    Workalemahu M. Berhanu, Ulrich H.E. Hansmann, Biomolecular Modelling and Simulations, 2014,

    CrossRef

  12. 12
    Amrutha Chilumuri, Mark Odell, Nathaniel G. N. Milton, Benzothiazole Aniline Tetra(ethylene glycol) and 3-Amino-1,2,4-triazole Inhibit Neuroprotection against Amyloid Peptides by Catalase Overexpression in Vitro, ACS Chemical Neuroscience, 2013, 4, 11, 1501

    CrossRef

  13. 13
    Juan R. Peinado, Furqan Sami, Nina Rajpurohit, Iris Lindberg, Blockade of islet amyloid polypeptide fibrillation and cytotoxicity by the secretory chaperones 7B2 and proSAAS, FEBS Letters, 2013, 587, 21, 3406

    CrossRef

  14. 14
    Workalemahu M. Berhanu, Fatih Yaşar, Ulrich H. E. Hansmann, In SilicoCross Seeding of Aβ and Amylin Fibril-like Oligomers, ACS Chemical Neuroscience, 2013, 4, 11, 1488

    CrossRef

  15. 15
    Nathan A Bernhardt, Workalemahu M. Berhanu, Ulrich H. E. Hansmann, Mutations and Seeding of Amylin Fibril-Like Oligomers, The Journal of Physical Chemistry B, 2013, 117, 50, 16076

    CrossRef